Dufaston (degidrosteron) in treatment of dysfunctional womb bleeding associated with ferrum hyperplasia of endometrium

Е. A. Ulrikh; Ульрих Е. А.; G. F. Kutusheva; Кутушева Г. Ф.; А. F. Urmancheeva; Урманчеева А. Ф.

doi:10.17816/JOWD88982

Dufaston (degidrosteron) in treatment of dysfunctional womb bleeding associated with ferrum hyperplasia of endometrium

作者: Ulrikh Е.A.¹^,2, Kutusheva G.F.¹^,2, Urmancheeva А.F.¹^,2
隶属关系:
1. Saint Petersburg Pediatric Medical Academy
2. Saint Petersburg State Medical Academy of Postgraduate Education
期: 卷 52, 编号 3 (2003)
页面: 60-63
栏目: Original study articles
URL: https://medbiosci.ru/jowd/article/view/88982
DOI: https://doi.org/10.17816/JOWD88982
ID: 88982

如何引用文章

全文:

详细
全文:
作者简介
参考
补充文件
统计

详细

Endometrial hyperplasia, being a fairly common gynecological pathology among women of different age groups, requires timely diagnosis and adequate treatment. Duphaston at a dosage of 10-20 mg from 5 to 25 or from 16 to 25 days of the menstrual cycle showed itself as an effective drug (in 83.3%), with sufficient progestogenic antiproliferative activity, with minimal side effects and a neutral effect on the metabolism of lipids and carbohydrates , which made it possible to use it among patients with various somatic pathologies.

关键词

endometrial hyperplasia, dysfunctional uterine bleeding, dydrogesterone (duphaston)

全文:

##article.viewOnOriginalSite##

参考

补充文件

附件文件

动作

1. JATS XML

下载

2. Figure: The efficacy of duphaston in the treatment of glandular hyperplasia of the endometrium in 30 patients aged 38 to 52 years

下载 (12KB)

索引源数据

用户名
密码
记住我

忘记您的密码?	注册

用户名
密码
记住我

忘记您的密码?	注册

Dufaston (degidrosteron) in treatment of dysfunctional womb bleeding associated with ferrum hyperplasia of endometrium

全文:

详细

关键词

全文:

作者简介

Е. Ulrikh

G. Kutusheva

А. Urmancheeva

参考

补充文件